Recently, the pharmaceutical industry machine vision inspection company "Aocheng Intelligence" once again received tens of millions of yuan of institutional A round investment, and the pharmaceutical machine vision inspection equipment of Aocheng Intelligent successfully entered the international market.
This round of investment is exclusively invested by Xiao Dining Table Venture Capital, with Gewu Capital acting as the exclusive financial advisor. The funds raised will be mainly used to promote the company's research and development and implementation of new pharmaceutical testing technologies and products, while continuing to promote the pharmaceutical testing equipment of Aocheng Intelligent into the markets of international developed countries.
At present, it has launched 360-degree capsule particle inspection series equipment, tablet particle detection equipment, controlled-release tablet center hole detection equipment, automatic intelligent blister testing machine and solid dosage pouch visual inspection module, instruction manual testing module, and is actively developing soft capsule production testing equipment and Chinese medicine pill production testing equipment. The customers of Aocheng Intelligent have covered many leading listed pharmaceutical enterprise groups in China and overseas pharmaceutical companies. In order to expand the international pharmaceutical industry vision inspection market more vigorously, Aocheng Intelligent has set up a wholly-owned subsidiary in North Carolina, USA. In addition to the establishment of a local technology R&D team, the US subsidiary of Aocheng Intelligent can provide market expansion and technical services to international pharmaceutical customers more conveniently and locally.
The intelligent automatic pharmaceutical testing equipment is connected to the pharmaceutical production line to realize unmanned automatic detection, which can well avoid drug contamination and missed detection, and greatly improve the efficiency and accuracy of drug detection.
The intelligent 360 capsule testing equipment can ensure the continuous production of capsule production lines in pharmaceutical production, while fully automatic identification of dozens of defects in the capsule production process, ensuring production quality and production efficiency.
The intelligent tablet testing equipment TCIM-3000 automatically identifies dozens of defects in the tablet production process to ensure the quality and efficiency of drug production.
According to data from high-tech production and research institutes, the size of China's machine vision market in 2019 was 6.55 billion yuan, a year-on-year increase of 21.8%. The agency also predicts that China's machine vision market will reach 15.56 billion yuan by 2023. From the perspective of downstream applications, in 2019, the consumer electronics, automobile manufacturing and food packaging industries accounted for a total of 70% of the share, while the pharmaceutical field targeted by Aocheng Intelligent accounted for about 9.7%, which is the third largest market for industrial machine vision inspection. The scale of China's pharmaceutical equipment industry in 2020 was 53.8 billion yuan, and it will reach about 87.5 billion yuan in 2025, with a compound growth rate of about 10.2% from 2020 to 2025. The international market opportunity of the pharmaceutical equipment industry is greater. The market size is 4-5 times that of China, and the price is 5-8 times that of China. The international market has a lot of room for expansion.
The "Intelligent Testing Equipment Industry Development Action Plan (2023-2025)" issued by the Ministry of Industry and Information Technology and the National Development and Reform Commission in early 2023 clearly pointed out that it is necessary to focus on and promote the large-scale application scenarios of eight intelligent testing equipment, including medicine. In the field of medicine, it is necessary to focus on improving technical products including machine vision recognition systems to realize intelligent detection of key production processes and packaging links of drugs. The technology and products of Aocheng Intelligent is one of the important directions for the country to promote intelligent manufacturing 2025.
The founding team of Aocheng Intelligent Company has many years of experience in product development, production and sales. Deep and unique understanding of pharmaceutical manufacturing regulations, processes and quality control requirements. The company focuses on technology and product research and development, and the R & D personnel account for more than 80%. All the core technologies of Aocheng Intelligent have independent intellectual property rights, and adopt an independent algorithm system including deep learning AI algorithm and pattern recognition, which meets the unique requirements of high speed, high precision and high reliability of pharmaceutical production inspection. AOCHENG Intelligent has a number of national invention patents and software copyrights for pharmaceutical machine vision inspection.
Zhang Xiaoyan, partner of Xiaofantable Venture Capital, said that high-quality and strong supervision are the general trend of the development of the pharmaceutical industry, and the automation rate of all links in the industry will be further improved. We recognize the entry point selected by Aocheng Intelligence, take the lead in focusing on the vertical application of machine vision in pharmaceutical scenarios, provide efficient, high-precision and cost-effective defect detection solutions for pharmaceutical companies, and have achieved product verification in leading pharmaceutical companies. The team of Aocheng Intelligent has many years of product development, landing and commercialization experience in the pharmaceutical equipment industry, which can quickly transform customer needs into products and continue to iterate, and we are full of confidence in the team's professional ability, entrepreneurial spirit and execution. It is also hoped that AUOCHENG can work hand in hand with Taizhou pharmaceutical industry to achieve a higher level of business.
Copyright © Aocheng Intelligence Technology (USA) Inc ICP No.: 京ICP备2020039748号Subscribe / Site Map
Technical Support: @2020-2099